Successful Treatment of Primary FSGS with LDL Apheresis

被引:0
|
作者
Nayak, Anjali B. [1 ]
Lozano-Guzman, German Andres [1 ]
Dandamudi, Raja [2 ]
Zaritsky, Joshua [1 ]
机构
[1] Phoenix Childrens Hosp, Phoenix, AZ USA
[2] Washington Univ, St Louis, MO 63110 USA
来源
关键词
D O I
10.1681/ASN.2024aekh8ytd
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
TH-PO623
引用
收藏
页数:2
相关论文
共 50 条
  • [21] LDL-apheresis in the treatment of familial hypercholesterolemia in childhood
    Stefanutti, C
    DiGiacomo, S
    Vivenzio, A
    Bosco, G
    Colloridi, V
    Trizza, S
    Berni, A
    Nigri, A
    Koga, N
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 383 - 384
  • [22] LDL and LP(a) apheresis for the treatment of severe lipid abnormalities
    Pokrovsky, S. N.
    Adamova, I. Y.
    Afanasieva, O. I.
    Kipor, S. G.
    Konovalov, G. A.
    Kulcharchuk, V. V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 186 - 186
  • [23] LDL apheresis in Italy
    Iacone, Antonio
    TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (03) : 211 - 212
  • [24] LDL apheresis in Japan
    Makino, Hisashi
    Tamanaha, Tamiko
    Harada-Shiba, Mariko
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (05) : 677 - 681
  • [25] Hypercholesterolemia and LDL apheresis
    Morelli, F
    Carlier, R
    Giannini, G
    De Luigi, MC
    Dejana, A
    Ruzzenenti, MR
    Valbonesi, M
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (10): : 1025 - 1031
  • [26] LDL APHERESIS BY IMMUNOADSORPTION
    OETTE, K
    BORBERG, H
    ATHEROSCLEROSIS VIII, 1989, 817 : 819 - 822
  • [27] Successful Management of Relapsing Primary FSGS with Tacrolimus and Mycophenolate Multitarget Therapy
    Lee, Frank
    Quizon, Marrey Ruby L.
    Lau, Wei Ling
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [28] Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS
    Laurin, Louis-Philippe
    Gasim, Adil M.
    Poulton, Caroline J.
    Hogan, Susan L.
    Jennette, J. Charles
    Falk, Ronald J.
    Foster, Bethany J.
    Nachman, Patrick H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (03): : 386 - 394
  • [29] LDL apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with hemodialysis treatment
    Inoue, I
    Takahashi, K
    Kikuchi, C
    Katayama, S
    DIABETES CARE, 1996, 19 (10) : 1103 - 1107
  • [30] Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients
    Heigl, Franz
    Hettich, Reinhard
    Suckfuell, Markus
    Luebbers, Christian W.
    Osterkorn, D.
    Osterkorn, K.
    Canis, Martin
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (05) : 95 - 101